BindingDB logo
myBDB logout

BDBM4074 8-ethyl-6-phenyl-2-(phenylamino)-7H,8H-pyrido[2,3-d]pyrimidin-7-one::pyrido[2,3-d]pyrimidin-7-one deriv. 47

SMILES: CCn1c2nc(Nc3ccccc3)ncc2cc(-c2ccccc2)c1=O

InChI Key: InChIKey=HSEYKDNBMMUBTH-UHFFFAOYSA-N

Data: 3 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 4074   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Platelet-derived growth factor receptor beta


(Homo sapiens (Human))
BDBM4074
PNG
(8-ethyl-6-phenyl-2-(phenylamino)-7H,8H-pyrido[2,3-...)
Show SMILES CCn1c2nc(Nc3ccccc3)ncc2cc(-c2ccccc2)c1=O
Show InChI InChI=1S/C21H18N4O/c1-2-25-19-16(13-18(20(25)26)15-9-5-3-6-10-15)14-22-21(24-19)23-17-11-7-4-8-12-17/h3-14H,2H2,1H3,(H,22,23,24)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/a 180n/an/an/an/an/an/a



Parke-Davis Pharmaceutical Research



Assay Description
IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...


J Med Chem 41: 4365-77 (1998)


Article DOI: 10.1021/jm980398y
BindingDB Entry DOI: 10.7270/Q2CC0XWN
More data for this
Ligand-Target Pair
Proto-oncogene tyrosine-protein kinase Src


(Homo sapiens (Human))
BDBM4074
PNG
(8-ethyl-6-phenyl-2-(phenylamino)-7H,8H-pyrido[2,3-...)
Show SMILES CCn1c2nc(Nc3ccccc3)ncc2cc(-c2ccccc2)c1=O
Show InChI InChI=1S/C21H18N4O/c1-2-25-19-16(13-18(20(25)26)15-9-5-3-6-10-15)14-22-21(24-19)23-17-11-7-4-8-12-17/h3-14H,2H2,1H3,(H,22,23,24)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/a 1.80E+3n/an/an/an/an/an/a



Parke-Davis Pharmaceutical Research



Assay Description
IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...


J Med Chem 41: 4365-77 (1998)


Article DOI: 10.1021/jm980398y
BindingDB Entry DOI: 10.7270/Q2CC0XWN
More data for this
Ligand-Target Pair
Fibroblast growth factor receptor 1


(Homo sapiens (Human))
BDBM4074
PNG
(8-ethyl-6-phenyl-2-(phenylamino)-7H,8H-pyrido[2,3-...)
Show SMILES CCn1c2nc(Nc3ccccc3)ncc2cc(-c2ccccc2)c1=O
Show InChI InChI=1S/C21H18N4O/c1-2-25-19-16(13-18(20(25)26)15-9-5-3-6-10-15)14-22-21(24-19)23-17-11-7-4-8-12-17/h3-14H,2H2,1H3,(H,22,23,24)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Patents


Similars

Article
PubMed
n/an/a 1.50E+3n/an/an/an/an/an/a



Parke-Davis Pharmaceutical Research



Assay Description
IC50 is the inhibitor concentration which inhibits 50% of kinase activity that catalyzes the transfer of the terminal phosphate from [gamma-32P] labe...


J Med Chem 41: 4365-77 (1998)


Article DOI: 10.1021/jm980398y
BindingDB Entry DOI: 10.7270/Q2CC0XWN
More data for this
Ligand-Target Pair